Biblio
“Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
, “Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1409-1423, 2016.
, “The Role of ADAM10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 2, pp. 303-322, 2017.
, “Genetically Determined Serum Uric Acid and Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1259-1265, 2018.
, “Differences in Dementia Beliefs between Non-Demented Public Screeners and In-Home Screeners and Their Potential Impact on Future Dementia Screening Intention: The Nakajima Study.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1651-1661, 2018.
, “Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1267-1281, 2018.
, “Amyloid Burden in Obstructive Sleep Apnea.”, J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
, “Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.”, J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
, “Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 265-275, 2017.
, “Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1013-20, 2016.
, “Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1183-1192, 2016.
, “Geographical Variation in the Diagnostic Rate and Quality of Dementia Diagnoses.”, J Alzheimers Dis, vol. 69, no. 2, pp. 513-520, 2019.
, “Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.”, J Alzheimers Dis, vol. 65, no. 3, pp. 963-976, 2018.
, “Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.”, J Alzheimers Dis, vol. 66, no. 1, pp. 347-357, 2018.
, “Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.”, J Alzheimers Dis, 2018.
, “Latent Cognitive Class at Enrollment Predicts Future Cognitive Trajectories of Decline in a Community Sample of Older Adults.”, J Alzheimers Dis, vol. 83, no. 2, pp. 641-652, 2021.
, “Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1053-1060, 2018.
, “Spatial Navigation in the Elderly with Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1683-1694, 2018.
, “Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities.”, J Alzheimers Dis, vol. 69, no. 4, pp. 979-987, 2019.
, “Do Chinese Researchers Conduct Ethical Research and Use Ethics Committee Review in Clinical Trials of Anti-Dementia Drugs? An Analysis of Biomedical Publications Originating from China.”, J Alzheimers Dis, vol. 52, no. 3, pp. 813-23, 2016.
, “Association between Cognitive Status before Surgery and Outcomes in Elderly Patients with Hip Fracture in a Dedicated Orthogeriatric Care Pathway.”, J Alzheimers Dis, vol. 56, no. 1, pp. 145-156, 2017.
, “From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S271-S279, 2018.
, “Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1311-9, 2016.
, “Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 52, no. 2, pp. 631-9, 2016.
, “Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.”, J Alzheimers Dis, vol. 53, no. 3, pp. 893-905, 2016.
,